Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease

Journal of Comparative Neurology

Volumn 493, Issue 2, 2005, Pages 261-273

  Cuenca, Nicolás ^a   Herrero, María Trinidad ^b   Angulo, Antonia ^a   De Juan, Emilio ^a   Martínez Navarrete, Gema C ^a   López, Salvador ^a   Barcia, Carlos ^b   Martín Nieto, José ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

AII amacrines; Connexin 36; Dopaminergic neurons; Parkinsonian monkeys; Retina

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEGENERATIVE DISEASE; DISABILITY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MONKEY; MORPHOLOGY; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NIGHT VISION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA ROD; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; VISUAL NERVOUS SYSTEM;

AMACRINE CELLS; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; PARKINSONIAN DISORDERS; RETINA; RETINAL BIPOLAR CELLS; SUBSTANTIA NIGRA; SYNAPSES;

EID: 27944469068     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20761     Document Type: Article

References (54)

1. Barcia C, Bautista V, Sánchez-Bahillo A, Fernández-Villalba E, Navarro-Ruis J-M, Fernández Barreiro A, Poza y Poza M, Herrero M-T. 2003. Circadian determinations of cortisol, prolactin, and melatonin in chronic MPTP-treated monkeys. Neuroendocrinology 78:118-128.
2. Bloomfield SA. 2001. Plasticity of AII amacrine cell circuitry in the mammalian retina. Prog Brain Res 131:185-200.
3. Bloomfield SA, Dacheux RF. 2001. Rod vision: pathways and processing in the mammalian retina. Prog Ret Eye Res 20:351-384.
4. Bodis-Wollner I. 1990. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci 13:296-302.
5. Bodis-Wollner I. 2003. Neuropsychological and perceptual defects in Parkinson's disease. Parkinsonism Rel Disord 9:S83-S89.
6. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. 1983. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci U S A 80:4546-4550.
7. Chen ST, Hsu JR, Hsu PC, Chuang JI. 2003. The retina as a novel in vivo model for studying the role of molecules of the Bcl-2 family in relation to MPTP neurotoxicity. Neurochem Res 28:805-814.
8. Colosimo C, de Michele M. 1999. Motor fluctuations in Parkinson's disease: pathophysiology and treatment. Eur J Neurol 6:1-21.
9. Contini M, Raviola E. 2003. GABAergic synapses made by a retinal dopaminergic neuron. Proc Natl Acad Sci U S A 100:1358-1363.
10. Cuenca N, Deng P, Linberg KA, Fisher SK, Kolb H. 2003. Choline acetyltransferase is expressed by non-starburst amacrine cells in the ground squirrel retina. Brain Res 964:21-30.
11. Deans MR, Volgyi B, Goodenough DA, Bloomfield SA, Paul DL. 2002. Connexin36 is essential for transmission of rod-mediated visual signals in the mammalian retina. Neuron 36:703-712.
12. Djamgoz MBA, Hankins MW, Hirano J, Archer SN. 1997. Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis Res 37:3509-3529.
13. Dong CJ, Hare WA. 2003. Temporal modulation of scotopic visual signals by A17 amacrine cells in mammalian retina in vivo. J Neurophysiol 89:2159-2166.
14. Ehinger B. 1983. Functional role of dopamine in the retina. In: Osborne NN, Chader GJ, editors. Progress in retinal research, vol 2. Oxford, United Kingdom: Pergamon Press, p 213-232.
15. Ellis CJK, Ikeda H. 1988. Evidence for retinal dopamine deficiency in Parkinson's disease. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic mechanisms in vision. New York: Alan R Liss, Inc. p 239-251.
16. Famiglietti EV Jr, Kolb H. 1976. Structural basis for ON- and OFF-center responses in retinal ganglion cells. Science 194:193-195.
17. Feigenspan A, Teubner B, Willecke K, Weiler R. 2001. Expression of neuronal connexin36 in All amacrine cells of the mammalian retina. J Neurosci 21:230-239.
18. Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover A. 1988a. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111:131-149.
19. Ghilardi MF, Chung E, Bodis-Wollner I, Dvorzniak M, Glover A, Onofrj M. 1988b. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sci 43:255-262.
20. Grünert U, Wässle H. 1990. GABA-like immunoreactivity in the macaque monkey retina: a light and electron microscopic study. J Comp Neurol 297:509-524.
21. Güldenagel M, Ammermüller J, Feigenspan A, Teubner B, Degen J, Söhl G, Willecke K, Weiler R. 2001. Visual transmission deficits in mice with targeted disruption of the gap junction gene connexin36. J Neurosci 21:6036-6044.
22. Harnois C, di Paolo T. 1990. Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci 31:2473-2475.
23. Herrero M-T, Pérez-Otano I, Oset C, Kastner A, Hirsch EC, Agid Y, Luquin MR, Obeso JA, del Río J. 1993. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience 56:965-972.
24. Ikeda H, Head GM, Ellis CJK. 1994. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vis Res 4:2629-2638.
25. Kolb H, Cuenca N, Dekorver L. 1991. Postembedding immunocytochemistry for GABA and glycine reveals the synaptic relationships of the dopaminergic amacrine cell of the cat retina. J Comp Neurol 310:267-284.
26. Kolb H, Zhang L, Dekorver L, Cuenca N. 2002. A new look at calretininimmunoreactive amacrine cell types in the monkey retina. J Comp Neurol 453:168-184.
27. Krubitzer L, Kahn DM. 2003. Nature versus nurture revisited: an old idea with a new twist. Prog Neurobiol 70:33-52.
28. Lach B, Grimes D, Benot B, Minkiewicz-Janda A. 1992. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material. Acta Neuropathol 83:352-360.
29. Langheinrich T, van Elst LT, Lagrèze WA, Bach M, Lucking CH, Greenlee MW. 2000. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 111:66-74.
30. Linberg K, Cuenca N, Ahnelt P, Fisher S, Kolb H. 2001. Comparative anatomy of major retinal pathways in the eyes of nocturnal and diurnal mammals. Prog Brain Res 131:27-52.
31. Luquin MR, Laguna J, Obeso JA. 1992. Selective D2 receptor stimulation induces dyskinesia in parkinsonian monkeys. Ann Neurol 31:551-554.
32. Mariani AP, Kolb H, Nelson R. 1984. Dopamine-containing amacrine cells of rhesus monkey retina parallel rods in spatial distribution. Brain Res 322:1-7.
33. Mariani AP, Neff NH, Hadjiconstantinou M. 1986. 1-Methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP) treatment decreases dopamine and increases lipofuscin in mouse retina. Neurosci Lett 72:221-226.
34. Marshak DW. 2001. Synaptic inputs to dopaminergic neurons in mammalian retinas. Prog Brain Res 131:83-91.
35. Masson G, Mestre D, Blin O. 1993. Dopaminergic modulation of visual sensitivity in man. Fund Clin Pharmacol 7:449-463.
36. McNeill TH, Brown SA, Rafols JA, Shoulson I. 1988. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 455:148-152.
37. Mills SL, Massey SC. 1999. All amacrine cells limit scotopic acuity in central macaque retina: a confocal analysis of calretinin labeling. J Comp Neurol 411:19-34.
38. Mills SL, O'Brien JJ, Li W, O'Brien J, Massey SC. 2001. Rod pathways in the mammalian retina use connexin 36. J Comp Neurol 436:336-350.
39. Nguyen-Legros J. 1988. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat 10:137-144.
40. Nguyen-Legros J, Harnois C, di Paolo I, Simon A. 1993. The retinal dopamine system in Parkinson's disease. Clin Vis Sci 8:1-12.
41. Paxinos G, Huang X-F, Toga AW. 1999. The rhesus monkey brain in stereotaxic coordinates. San Diego: Academic Press.
42. Pierelli F, Stanzione P, Peppe A, Stefano E, Rizzo PA, Bernardi G, Morocutti C. 1988. Electrophysiological (PERG,VEP) abnormalities in Parkinson disease are reversed by L-DOPA. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic mechanisms in vision. New York: Alan R Liss, Inc. p 253-265.
43. Pow DV, Wright LL, Vaney DI. 1995. The immunocytochemical detection of amino-acid neurotransmitters in paraformaldehyde-fixed tissues. J Neurosci Methods 56:115-123.
44. Ramón y Cajal S. 1892. The structure of the retina. Thorpe SA, Glickstein M, translators. 1972. Springfield, IL: Charles C. Thomas Publisher.
45. Rodnitzky RL. 1998. Visual dysfunction in Parkinson's disease. Clin Neurosci 5:102-106.
46. Saszik SM, Robson JG, Frishman LJ. 2002. The scotopic threshold response of the dark-adapted electroretinogram of the mouse. J Physiol 543:899-916.
47. Tatton WG, Kwan MM, Verrier MC, Seniuk NA, Theriault E. 1990. MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells. Brain Res 527:21-31.
48. Van Laar T. 2003. Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management. CNS Drugs 17:475-489.
49. Veruki ML, Wässle H. 1996. Immunohistochemical localization of dopamine D1 receptors in rat retina. Eur J Neurosci 8:2286-2297.
50. Voigt T, Wässle H. 1987. Dopaminergic innervation of AII amacrine cells in mammalian retina. J Neurosci 7:4115-4128.
51. Wässle H, Chun MH. 1988. Dopaminergic and indoleamine-accumulating amacrine cells express GABA-like immunoreactivity in the cat retina. J Neurosci 8:3383-3394.
52. Wässle H, Grünert U, Chun MH, Boycott BB. 1995. The rod pathway of the macaque monkey retina: identification of AII-amacrine cells with antibodies against calretinin. J Comp Neurol 361:537-551.
53. Witkovsky P. 2004. Dopamine and retinal function. Doc Ophthalmol 108: 17-40.
54. Wong C, Ishibashi T, Tucker G, Hamasaki D. 1985. Responses of the pigmented rabbit retina to NMPTP, a chemical inducer of parkinsonism. Exp Eye Res 40:509-519.